Ragnhild Wergeland

     

    Publications 2012

    Askevold ET, Nymo S, Ueland T, Gravning J, Wergeland R, Kjekshus J, Yndestad A, Cleland JG, McMurray JJ, Aukrust P, Gullestad L (2012)
    Soluble glycoprotein 130 predicts fatal outcomes in chronic heart failure: analysis from the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA)
    Circ Heart Fail, 6 (1), 91-8
    DOI 10.1161/CIRCHEARTFAILURE.112.972653, PubMed 23230311

    Broch K, Eek C, Wergeland R, Ueland T, Skårdal R, Aukrust P, Skulstad H, Gullestad L (2012)
    NT-proBNP predicts myocardial recovery after non-ST-elevation acute coronary syndrome
    Scand Cardiovasc J, 46 (2), 65-71
    DOI 10.3109/14017431.2011.652981, PubMed 22191851

    Solberg OG, Ueland T, Wergeland R, Dahl CP, Aakhus S, Aukrust P, Gullestad L (2012)
    High-sensitive troponin T and N-terminal-brain-natriuretic-peptide predict outcome in symptomatic aortic stenosis
    Scand Cardiovasc J, 46 (5), 278-85
    DOI 10.3109/14017431.2012.687836, PubMed 22545649

    Publications 2011

    Aarones M, Gullestad L, Aakhus S, Ueland T, Skaardal R, Aass H, Wergeland R, Smith HJ, Aukrust P, Kongsgaard E (2011)
    Prognostic value of cardiac troponin T in patients with moderate to severe heart failure scheduled for cardiac resynchronization therapy
    Am Heart J, 161 (6), 1031-7
    DOI 10.1016/j.ahj.2010.09.021, PubMed 21641347

    Publications 2010

    Aarønæs M, Aakhus S, Aass H, Moum T, Wergeland R, Gullestad L, Kongsgård E (2010)
    Assessment of response criteria to cardiac resynchronization therapy (CRT) and prediction of response
    Scand Cardiovasc J, 44 (6), 337-45
    DOI 10.3109/14017431.2010.508537, PubMed 21080864

    Publications 2009

    Arora S, Aukrust P, Ueland T, Broch K, Simonsen S, Gude E, Fiane AE, Geiran O, Wergeland R, Andreassen AK, Gullestad L (2009)
    Elevated serum uric acid levels following heart transplantation predict all-cause and cardiac mortality
    Eur J Heart Fail, 11 (10), 1005-13
    DOI 10.1093/eurjhf/hfp115, PubMed 19737803

    Publications 2007

    Arora S, Gullestad L, Wergeland R, Simonsen S, Holm T, Hognestad A, Ueland T, Geiran O, Andreassen A (2007)
    Probrain natriuretic peptide and C-reactive protein as markers of acute rejection, allograft vasculopathy, and mortality in heart transplantation
    Transplantation, 83 (10), 1308-15
    DOI 10.1097/01.tp.0000263338.39555.21, PubMed 17519779

    Johansen OE, Birkeland KI, Orvik E, Flesland Ø, Wergeland R, Ueland T, Smith C, Endresen K, Aukrust P, Gullestad L (2007)
    Inflammation and coronary angiography in asymptomatic type 2 diabetic subjects
    Scand J Clin Lab Invest, 67 (3), 306-16
    DOI 10.1080/00365510601045088, PubMed 17454845

    Omland T, Sabatine MS, Jablonski KA, Rice MM, Hsia J, Wergeland R, Landaas S, Rouleau JL, Domanski MJ, Hall C, Pfeffer MA, Braunwald E, PEACE Investigators (2007)
    Prognostic value of B-Type natriuretic peptides in patients with stable coronary artery disease: the PEACE Trial
    J Am Coll Cardiol, 50 (3), 205-14
    DOI 10.1016/j.jacc.2007.03.038, PubMed 17631211

    Wethal T, Kjekshus J, Røislien J, Ueland T, Andreassen AK, Wergeland R, Aukrust P, Fosså SD (2007)
    Treatment-related differences in cardiovascular risk factors in long-term survivors of testicular cancer
    J Cancer Surviv, 1 (1), 8-16
    DOI 10.1007/s11764-007-0012-3, PubMed 18648940

    Publications 2006

    Andreassen AK, Wergeland R, Simonsen S, Geiran O, Guevara C, Ueland T (2006)
    N-terminal pro-B-type natriuretic peptide as an indicator of disease severity in a heterogeneous group of patients with chronic precapillary pulmonary hypertension
    Am J Cardiol, 98 (4), 525-9
    DOI 10.1016/j.amjcard.2006.02.061, PubMed 16893710

    Bollerslev J, Ueland T, Jørgensen AP, Fougner KJ, Wergeland R, Schreiner T, Burman P (2006)
    Positive effects of a physiological dose of GH on markers of atherogenesis: a placebo-controlled study in patients with adult-onset GH deficiency
    Eur J Endocrinol, 154 (4), 537-43
    DOI 10.1530/eje.1.02125, PubMed 16556716

    Heringlake M, Will B, Klaus S, Heinze H, Wagner K, Pagel H, Wergeland R, Bahlmann L (2006)
    The effects of angiotensin-converting enzyme inhibition on the urinary excretion of NTproBNP in male volunteers
    Kidney Blood Press Res, 29 (5), 294-305
    DOI 10.1159/000096352, PubMed 17057415

    Holm T, Ueland T, Halvorsen B, Hognestad A, Holm AG, Wergeland R, Gullestad L, Aukrust P, Kjekshus J (2006)
    A protective anti-inflammatory phenotype in high-risk individuals who do not develop coronary artery disease
    J Am Coll Cardiol, 47 (5), 1085-6
    DOI 10.1016/j.jacc.2005.11.042, PubMed 16516099

    Kurz K, Voelker R, Zdunek D, Wergeland R, Hess G, Ivandic B, Katus H, Giannitsis E (2006)
    Effect of stress-induced reversible ischemia on serum concentrations of ischemia-modified albumin, natriuretic peptides and placental growth factor
    Clin Res Cardiol, 96 (3), 152-9
    DOI 10.1007/s00392-007-0469-5, PubMed 17180576

    Olsen MH, Wachtell K, Nielsen OW, Hall C, Wergeland R, Ibsen H, Kjeldsen SE, Devereux RB, Dahlöf B, Hildebrandt PR (2006)
    N-terminal brain natriuretic peptide predicted cardiovascular events stronger than high-sensitivity C-reactive protein in hypertension: a LIFE substudy
    J Hypertens, 24 (8), 1531-9
    DOI 10.1097/01.hjh.0000239288.10013.04, PubMed 16877955

    Publications 2005

    Fiane AE, Ueland T, Simonsen S, Scott H, Endresen K, Gullestad L, Geiran OR, Haraldsen G, Heggelund L, Andreassen AK, Wergeland R, Frøland S, Aukrust P, Mollnes TE (2005)
    Low mannose-binding lectin and increased complement activation correlate to allograft vasculopathy, ischaemia, and rejection after human heart transplantation
    Eur Heart J, 26 (16), 1660-5
    DOI 10.1093/eurheartj/ehi198, PubMed 15821010

    Gullestad L, Ueland T, Fjeld JG, Holt E, Gundersen T, Breivik K, Følling M, Hodt A, Skårdal R, Kjekshus J, Andreassen A, Kjekshus E, Wergeland R, Yndestad A, Frøland SS, Semb AG, Aukrust P (2005)
    Effect of thalidomide on cardiac remodeling in chronic heart failure: results of a double-blind, placebo-controlled study
    Circulation, 112 (22), 3408-14
    DOI 10.1161/CIRCULATIONAHA.105.564971, PubMed 16301340

    Hognestad A, Endresen K, Wergeland R, Mellembakken JR, Mollnes TE, Omland T, Kjekshus JK, Aukrust P, Andreassen AK (2005)
    Inflammatory response and re-stenosis after percutaneous coronary intervention in heart transplant recipients and patients with native atherosclerosis
    J Heart Lung Transplant, 24 (8), 1026-32
    DOI 10.1016/j.healun.2004.07.018, PubMed 16102437

    Michelsen AE, Wergeland R, Stokke O, Brosstad F (2005)
    Development of a time-resolved immunofluorometric assay for quantifying platelet-derived microparticles in human plasma
    Thromb Res, 117 (6), 705-11
    DOI 10.1016/j.thromres.2005.05.024, PubMed 15990159

    Omland T, Richards AM, Wergeland R, Vik-Mo H (2005)
    B-type natriuretic peptide and long-term survival in patients with stable coronary artery disease
    Am J Cardiol, 95 (1), 24-8
    DOI 10.1016/j.amjcard.2004.08.058, PubMed 15619389

    Publications 2004

    Heringlake M, Heide C, Bahlmann L, Eichler W, Pagel H, Schmucker P, Wergeland R, Armbruster FP, Klaus S (2004)
    Effects of tilting and volume loading on plasma levels and urinary excretion of relaxin, NT-pro-ANP, and NT-pro-BNP in male volunteers
    J Appl Physiol (1985), 97 (1), 173-9
    DOI 10.1152/japplphysiol.01196.2003, PubMed 14990550

    Hognestad A, Aukrust P, Wergeland R, Stokke O, Gullestad L, Semb AG, Holm T, Andreassen AK, Kjekshus JK (2004)
    Effects of conventional and aggressive statin treatment on markers of endothelial function and inflammation
    Clin Cardiol, 27 (4), 199-203
    DOI 10.1002/clc.4960270405, PubMed 15119693

    Publications 2003

    Hognestad A, Endresen K, Wergeland R, Stokke O, Geiran O, Holm T, Simonsen S, Kjekshus JK, Andreassen AK (2003)
    Plasma C-reactive protein as a marker of cardiac allograft vasculopathy in heart transplant recipients
    J Am Coll Cardiol, 42 (3), 477-82
    DOI 10.1016/s0735-1097(03)00645-4, PubMed 12906976

    Publications 2002

    Djurovic S, Clausen T, Wergeland R, Brosstad F, Berg K, Henriksen T (2002)
    Absence of enhanced systemic inflammatory response at 18 weeks of gestation in women with subsequent pre-eclampsia
    BJOG, 109 (7), PII S1470-0328(02)01330-7-764

    Djurovic S, Clausen T, Wergeland R, Brosstad F, Berg K, Henriksen T (2002)
    Absence of enhanced systemic inflammatory response at 18 weeks of gestation in women with subsequent pre-eclampsia
    BJOG, 109 (7), 759-64
    PubMed 12135211

    Publications 2001

    Oyen O, Wergeland R, Bentdal O, Hartmann A, Brekke IB, Stokke O (2001)
    Serial ultrasensitive CRP measurements may be useful in rejection diagnosis after kidney transplantation
    Transplant Proc, 33 (4), 2481-3
    DOI 10.1016/s0041-1345(01)02070-x, PubMed 11406220

    Publications 1999

    Wergeland R, Oyen O, Bentdal O, Stokke O (1999)
    MicroCRP: a highly sensitive CRP method applied in the monitoring of renal allograft recipients
    Scand J Clin Lab Invest, 59 (6), 405-16
    DOI 10.1080/00365519950185427, PubMed 10612551

    Publications 1996

    Thoresen SI, Wergeland R, Mørkrid L, Stokke O (1996)
    Evaluation of an enzymatic immunoassay for free thyroxine determination in canine serum
    Vet Res Commun, 20 (5), 411-20
    DOI 10.1007/BF00419178, PubMed 8908721

    Publications 1995

    Bjøro T, Mørkrid L, Wergeland R, Turter A, Kvistborg A, Sand T, Torjesen P (1995)
    Frequency of hyperprolactinaemia due to large molecular weight prolactin (150-170 kD PRL)
    Scand J Clin Lab Invest, 55 (2), 139-47
    DOI 10.3109/00365519509089606, PubMed 7667607

    Publications 1994

    HOLTE A, MIKKELSEN A, MOEN MH, SKJOERASEN J, JERVELL J, STOKKE KT, WERGELAND R (1994)
    PSYCHOSOCIAL FACTORS AND THE MENOPAUSE - RESULTS FROM THE NORWEGIAN MENOPAUSE PROJECT
    I C S S, 8, 169-175

    Publications 1993

    WERGELAND R, MORKRID L, ABYHOLM T (1993)
    EVALUATION OF THE ABBOTT IMX ESTRADIOL ASSAY
    J. Clin. Immunoass., 16 (3), 238-243

    Publications 1986

    STOKKE KT, ROOTWELT K, WERGELAND R, VALE JR (1986)
    CHANGES IN PLASMA AND RED-CELL VOLUMES DURING EXPOSURE TO HIGH-ALTITUDE
    Scand. J. Clin. Lab. Invest., 46 184, 113-117

    Stokke KT, Rootwelt K, Wergeland R, Vale JR (1986)
    Changes in plasma and red cell volumes during exposure to high altitude
    Scand J Clin Lab Invest Suppl, 184, 113-7
    PubMed 3473608

    Taubøll E, Gjerstad L, Stokke KT, Wergeland R (1986)
    No monthly variations in serum levels of thyroid hormones in human males
    Horm Metab Res, 18 (7), 500-1
    DOI 10.1055/s-2007-1012358, PubMed 3744295

    Publications 1984

    Opstad PK, Falch D, Oktedalen O, Fonnum F, Wergeland R (1984)
    The thyroid function in young men during prolonged exercise and the effect of energy and sleep deprivation
    Clin Endocrinol (Oxf), 20 (6), 657-69
    DOI 10.1111/j.1365-2265.1984.tb00116.x, PubMed 6432374

    Rootwelt K, Wergeland R, Lie SO, Natvig K (1984)
    [Thyroglobulin in serum. A useful diagnostic test in cancer of the thyroid, thyrotoxicosis factitia, athyreosis/ectopy and hereditary dyshormonogenesis]
    Tidsskr Nor Laegeforen, 104 (4), 231-5
    PubMed 6701866

    Page visits: 4016